Tenosynovial Giant Cell Tumor — Trials

Tenosynovial Giant Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04703322	A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan	completed	Phase 2	9	Daiichi Sankyo Co., Ltd.INDUSTRY	1	Jun 24, 2026	clinicaltrials
NCT01207492	Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor	completed	Phase 2	17	Andrew J. Wagner, MD, PhDOTHER	1	Feb 20, 2026	clinicaltrials
NCT05349643	A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT	completed	Phase 2	20	AmMax Bio, Inc.INDUSTRY	3	Jul 5, 2024	clinicaltrials
NCT04731675	An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

Data updated 23 days agoSource updated Jun 24, 2026source: clinicaltrials